Provided by Tiger Fintech (Singapore) Pte. Ltd.

Global Partners LP

54.70
+0.75001.39%
Post-market: 55.941.24+2.27%19:42 EDT
Volume:86.22K
Turnover:4.72M
Market Cap:1.84B
PE:22.70
High:55.89
Open:53.57
Low:53.42
Close:53.95
Loading ...

Americans Face Challenges to Access GLP-1 Medication -- Market Talk

Dow Jones
·
14 Nov 2024

Lexaria Bioscience Advances GLP-1 Study

TIPRANKS
·
14 Nov 2024

Altimmune’s pemvidutide looks differentiated among GLP-1s, says H.C. Wainwright

TIPRANKS
·
14 Nov 2024

Hims & Hers launches GLP-1 shortage tracker in its battle with the FDA

Yahoo Finance
·
13 Nov 2024

Lexaria Bioscience receives HREC approval for Phase 1b DehydraTECH GLP-1 study

TIPRANKS
·
13 Nov 2024

Ethics Board Approval Granted for Lexaria's 12-Week Phase 1b DehydraTECH GLP-1 Study in Diabetes and Weight Loss

ACCESSWIRE
·
13 Nov 2024

Americans Continue to Struggle to Access Branded GLP-1s as Shortages Continue

Business Wire
·
13 Nov 2024

Stifel Nicolaus Keeps Their Buy Rating on Global Partners (GLP)

TIPRANKS
·
12 Nov 2024

From GLP-1 Drugs To Catastrophic Claims – Why Employer Health Premiums Are Skyrocketing In 2025

Benzinga
·
10 Nov 2024

Global Partners LP (GLP) Q3 2024 Earnings Call Highlights: Strong Financial Performance and ...

GuruFocus.com
·
09 Nov 2024

Global Partners to 'Accelerate' Installation of EV Fast Chargers with NEVI Program -- OPIS

Dow Jones
·
09 Nov 2024

Hims & Hers Sticking with Weight-Loss Even If GLP-1 Shortage Ends -- Market Talk

Dow Jones
·
09 Nov 2024

Global Partners Benefits From Lofty Retail Markets, Integration of Terminals -- OPIS

Dow Jones
·
09 Nov 2024

Global Partners' Q3 Earnings, Revenue Increase

MT Newswires Live
·
08 Nov 2024

Global Partners GAAP EPS of $1.17, revenue of $4.42B

seekingalpha
·
08 Nov 2024

Global Partners Q3 2024 GAAP EPS $1.17 Misses $1.57 Estimate, Sales $4.422B Miss $5.876B Estimate

Benzinga
·
08 Nov 2024